Laparoscopic and Robotic Surgery for Endometrial and Cervical Cancer

Area of Science:

• Gynecologic Oncology
• Surgical Innovation
• Evidence-Based Medicine

Background:

• Minimally invasive surgery (MIS) offers benefits like reduced morbidity and faster recovery.
• Establishing oncological efficacy and safety is crucial before adopting new surgical techniques, especially in cancer treatment.

Purpose of the Study:

• To comprehensively review contentious and topical themes regarding MIS in endometrial and cervix cancer treatment.
• To evaluate the oncological efficacy and safety of MIS in gynecologic oncology.

Main Methods:

• Thorough literature review of existing studies on MIS for endometrial and cervical cancers.
• Analysis of current evidence regarding surgical approaches, patient challenges, and specific oncological outcomes.

Main Results:

• MIS is the established standard of care for endometrial cancer, including laparoscopy and robotic surgery.
• For cervical cancer, the open approach is recommended as the gold standard for early-stage disease; MIS use is primarily for research.
• Specific topics like fertility-sparing treatments, sentinel lymph node assessment, and management of complex patients (obese, elderly) were discussed.

Conclusions:

• MIS is the current standard for endometrial cancer treatment.
• The role of MIS in cervical cancer management requires further research, with the open approach being the gold standard for early-stage disease.
• Informed patient consent detailing risks and benefits is paramount for both conditions.